MANCUSO, MICHELANGELO
 Distribuzione geografica
Continente #
NA - Nord America 15.631
EU - Europa 6.136
AS - Asia 1.988
AF - Africa 291
OC - Oceania 36
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.117
Nazione #
US - Stati Uniti d'America 15.258
IT - Italia 2.327
SE - Svezia 1.126
CN - Cina 1.034
DE - Germania 816
BG - Bulgaria 684
CA - Canada 344
GB - Regno Unito 311
VN - Vietnam 268
TR - Turchia 264
UA - Ucraina 220
FI - Finlandia 189
CI - Costa d'Avorio 178
SG - Singapore 167
AT - Austria 137
HK - Hong Kong 115
CH - Svizzera 89
RU - Federazione Russa 63
IN - India 59
SN - Senegal 59
NG - Nigeria 54
FR - Francia 47
BE - Belgio 41
IL - Israele 30
NL - Olanda 27
MX - Messico 22
NZ - Nuova Zelanda 21
ES - Italia 16
AU - Australia 15
JP - Giappone 11
IR - Iran 10
EC - Ecuador 8
EU - Europa 8
PL - Polonia 8
BR - Brasile 7
DK - Danimarca 7
KR - Corea 7
CL - Cile 6
GR - Grecia 6
TW - Taiwan 6
CZ - Repubblica Ceca 4
ID - Indonesia 4
IE - Irlanda 4
TH - Thailandia 4
CU - Cuba 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
AR - Argentina 2
CR - Costa Rica 2
HU - Ungheria 2
MY - Malesia 2
OM - Oman 2
AL - Albania 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
DM - Dominica 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
ME - Montenegro 1
SV - El Salvador 1
Totale 24.117
Città #
Woodbridge 2.446
Fairfield 1.953
Houston 1.552
Ann Arbor 1.441
Chandler 1.181
Ashburn 937
Seattle 861
Sofia 682
Wilmington 675
Milan 649
Cambridge 621
Serra 578
Beijing 422
New York 417
Ottawa 328
Jacksonville 311
Princeton 290
Lawrence 274
Izmir 258
Medford 246
Nanjing 181
Abidjan 178
Florence 152
Des Moines 130
Vienna 129
Frankfurt am Main 112
Hong Kong 107
San Diego 104
Dong Ket 96
Bern 83
Nanchang 82
Rome 77
London 74
Dearborn 71
Pisa 71
Redwood City 62
Dakar 59
Norwalk 59
Jüchen 58
Lagos 54
Kunming 51
Bremen 49
Hebei 44
Lancaster 39
Boulder 36
Brussels 35
Shenyang 34
Changsha 33
Los Angeles 33
Pune 32
Falls Church 30
Washington 29
Jiaxing 27
Hefei 20
Nürnberg 20
Ogden 19
Tianjin 19
Boardman 18
Auburn Hills 17
Shanghai 16
Detroit 15
Hangzhou 14
Lappeenranta 14
Bat Yam 12
Singapore 12
Leawood 11
Mexico 11
Chicago 10
Phoenix 10
San Francisco 10
Tappahannock 10
Auckland 9
Council Bluffs 9
Guangzhou 9
Orange 9
Changchun 8
Christchurch 8
Enterprise 8
Siena 8
Düsseldorf 7
Jinan 7
Tokyo 7
Toronto 7
Warsaw 7
Ardabil 6
Genoa 6
Lanzhou 6
Nijmegen 6
Ningbo 6
Redmond 6
San Mateo 6
Verona 6
Bologna 5
Central District 5
Chengdu 5
Copenhagen 5
Indiana 5
Kilburn 5
Taipei 5
Vicopisano 5
Totale 18.982
Nome #
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 182
IER-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Thrombectomy for Stroke 180
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 171
Mitochondrial DNA-related disorders 167
Antimyoclonic effect of levetiracetam in MERRF syndrome 166
Mitochondria, cognitive impairment, and Alzheimer's disease. 166
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 159
An atypical presentation of sporadic adult-onset centronuclear myopathy 156
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 155
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 154
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 154
Inflammatory myopathy in a patient with postural and kinetik tremor. 153
Metabolic myopathies: functional evaluation by different exercise testing approaches 153
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 149
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 148
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 148
Psychiatric involvement in adult patients with mitochondrial disease. 146
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 143
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 143
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 142
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 142
Mitochondrial DNA single deletion in a patient with postural tremor. 141
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 141
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 140
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 140
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 140
Mitochondria and neurodegeneration 139
Reply to P.M. Foye ( Letter ) 139
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 139
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 138
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 138
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? 137
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 134
Mitochondrial peripheral benzodiazepine receptor in amyotrophic lateral sclerosis 133
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 133
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 132
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 132
Mitochondrial dysfunction and Alzheimer's disease: new developments 131
A new truncating MPZ mutation associated with a very mild CMT1 B phenotype 131
Drugs and mitochondrial diseases: 40 queries and answers. 131
Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy 131
The Role of Mitochondria in StemCell Biology 130
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 130
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 129
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 128
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 128
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 127
Vertebrobasilar recording with contrast transcranial Doppler in right-to-left shunt diagnosis 127
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 126
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 125
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 124
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 123
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study 123
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 122
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 122
Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia 121
Mitochondrial DNA sequence variation and neurodegeneration. 121
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 121
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 121
Tetracycline treatment in patients with progressive external ophthalmoplegia. 118
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 118
Aging with Cerebral Small Vessel Disease and Dizziness: The Importance of Undiagnosed Peripheral Vestibular Disorders 118
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 117
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 117
POLG1-related and other "mitochondrial Parkinsonisms": an overview. 117
Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. 116
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 116
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 113
H-MTTFA muscle levels in mitochondrial myopathies. 113
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 113
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 112
DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patients. 112
G41S SOD1 mutation: A common ancestor for six ALS Italian families with an aggressive phenotype 111
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 111
Sudden bilateral hearing loss and sporadic mitochondrial DNA deletion. 109
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. 109
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 109
Transient ischemic attack in hereditary hemorrhagic telangiectasia 109
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 109
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 108
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 108
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 108
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. 105
Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. 105
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 105
Cytogenetic damage in peripheral lymphocytes of mitochondrial disease patients 104
dissection and atherosclerosis of carotid arteries in the young: role of the apolipoprotein E polymorphism 104
Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. 104
Genetics of ischaemic stroke in young adults 103
Amyotrophic Lateral Sclerosis and Oxidative Stress: a Double-Blind Therapeutic Trial After Curcumin Supplementation 103
ANTIOXIDANT CAPACITY AND PROTEIN OXIDATION IN CEREBROSPINAL FLUID AF ALS 102
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation 102
D90A-SOD1 mutation in ALS: The first report of heterozygous Italian patients and unusual findings. 102
.Is there a primary role of the mitochondrial genome in Alzheimer's disease? 102
Anticoagulation After Stroke in Patients With Atrial Fibrillation 102
Absence of angiogenic genes modification in Italian ALS patients 101
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 101
Abnormal H-Tfam in a patient harboring a single mtDNA deletion. 101
Molecular diagnostics and mitochondrial dysfunction: a future perspective 100
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 100
Totale 12.682
Categoria #
all - tutte 63.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.291 0 0 0 0 0 0 0 0 0 0 714 577
2019/20205.208 596 393 613 324 481 485 532 403 517 333 440 91
2020/20212.215 203 175 129 117 216 139 121 203 214 174 183 341
2021/20222.959 55 197 68 185 561 382 89 169 139 76 250 788
2022/20233.808 445 484 250 330 455 450 36 297 727 25 271 38
2023/20242.674 353 307 351 210 436 543 132 97 47 196 2 0
Totale 24.505